Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mirko Theis

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
EMBO Reports|October 16, 2020
MLLT6 maintains PD-L1 expression and mediates tumor immune resistanceSandeep Sreevalsan, Marietta Döring, Maciej Paszkowski-Rogacz, et al.
Life Science Alliance|March 15, 2022
DNA methylation-independent long-term epigenetic silencing with dCRISPR/Cas9 fusion proteinsLi Ding, Lukas Theo Schmitt, Melanie Brux, et al.
Plos One|August 20, 2011
An RNA interference phenotypic screen identifies a role for FGF signals in colon cancer progressionMarc Leushacke, Ralf Spörle, Christof Bernemann, et al.
Journal of the National Cancer Institute|September 1, 2016
Inactivation of Cancer Mutations Utilizing CRISPR/Cas9Christina Gebler, Tim Lohoff, Maciej Paszkowski-Rogacz, et al.
Nature Communications|November 4, 2017
Genome-scale single-cell mechanical phenotyping reveals disease-related genes involved in mitotic roundingYusuke Toyoda, Cedric J Cattin, Martin P Stewart, et al.
Cancer Gene Therapy|February 6, 2025
Methylstat sensitizes ovarian cancer cells to PARP-inhibition by targeting the histone demethylases JMJD1B/CFranziska Maria Schwarz, Daniel Martin Klotz, Ruming Yang, et al.
Nature Methods|February 14, 2012
Combined RNAi and localization for functionally dissecting long noncoding RNAsDebojyoti Chakraborty, Dennis Kappei, Mirko Theis, et al.
Blood|May 2, 2015
RNAi profiling of primary human AML cells identifies ROCK1 as a therapeutic target and nominates fasudil as an antileukemic drugMartin Wermke, Aylin Camgoz, Maciej Paszkowski-Rogacz, et al.
Cellular Oncology (Dordrecht, Netherlands)|December 28, 2021
Loss of USP28 and SPINT2 expression promotes cancer cell survival after whole genome doublingSara Vanessa Bernhard, Katarzyna Seget-Trzensiok, Christian Kuffer, et al.
Cancers|August 12, 2023
Establishment and Molecular Characterization of an In Vitro Model for PARPi-Resistant Ovarian CancerDaniel Martin Klotz, Franziska Maria Schwarz, Anna Dubrovska, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
EMBO Reports|October 16, 2020
MLLT6 maintains PD-L1 expression and mediates tumor immune resistanceSandeep Sreevalsan, Marietta Döring, Maciej Paszkowski-Rogacz, et al.
Life Science Alliance|March 15, 2022
DNA methylation-independent long-term epigenetic silencing with dCRISPR/Cas9 fusion proteinsLi Ding, Lukas Theo Schmitt, Melanie Brux, et al.
Plos One|August 20, 2011
An RNA interference phenotypic screen identifies a role for FGF signals in colon cancer progressionMarc Leushacke, Ralf Spörle, Christof Bernemann, et al.
Journal of the National Cancer Institute|September 1, 2016
Inactivation of Cancer Mutations Utilizing CRISPR/Cas9Christina Gebler, Tim Lohoff, Maciej Paszkowski-Rogacz, et al.
Nature Communications|November 4, 2017
Genome-scale single-cell mechanical phenotyping reveals disease-related genes involved in mitotic roundingYusuke Toyoda, Cedric J Cattin, Martin P Stewart, et al.
Cancer Gene Therapy|February 6, 2025
Methylstat sensitizes ovarian cancer cells to PARP-inhibition by targeting the histone demethylases JMJD1B/CFranziska Maria Schwarz, Daniel Martin Klotz, Ruming Yang, et al.
Nature Methods|February 14, 2012
Combined RNAi and localization for functionally dissecting long noncoding RNAsDebojyoti Chakraborty, Dennis Kappei, Mirko Theis, et al.
Blood|May 2, 2015
RNAi profiling of primary human AML cells identifies ROCK1 as a therapeutic target and nominates fasudil as an antileukemic drugMartin Wermke, Aylin Camgoz, Maciej Paszkowski-Rogacz, et al.
Cellular Oncology (Dordrecht, Netherlands)|December 28, 2021
Loss of USP28 and SPINT2 expression promotes cancer cell survival after whole genome doublingSara Vanessa Bernhard, Katarzyna Seget-Trzensiok, Christian Kuffer, et al.
Cancers|August 12, 2023
Establishment and Molecular Characterization of an In Vitro Model for PARPi-Resistant Ovarian CancerDaniel Martin Klotz, Franziska Maria Schwarz, Anna Dubrovska, et al.
Pageof 3